Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,412
  • Shares Outstanding, K 49,563
  • Annual Sales, $ 96,630 K
  • Annual Income, $ -63,320 K
  • EBIT $ -49 M
  • EBITDA $ -40 M
  • 60-Month Beta 1.22
  • Price/Sales 1.28
  • Price/Cash Flow N/A
  • Price/Book 9.26

Options Overview Details

View History
  • Implied Volatility 247.93% ( +153.90%)
  • Historical Volatility 102.28%
  • IV Percentile 93%
  • IV Rank 69.25%
  • IV High 357.36% on 10/16/24
  • IV Low 1.48% on 01/09/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 790
  • Open Int (30-Day) 742

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.12
  • Low Estimate -0.18
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +31.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +22.66%
on 12/05/24
2.70 -7.78%
on 12/11/24
+0.33 (+15.28%)
since 11/20/24
3-Month
1.99 +25.12%
on 11/18/24
3.32 -24.97%
on 11/11/24
-0.39 (-13.54%)
since 09/20/24
52-Week
1.88 +32.45%
on 05/23/24
6.31 -60.54%
on 03/04/24
-2.22 (-47.13%)
since 12/20/23

Most Recent Stories

More News
Akoya Biosciences and NeraCare Forge Exclusive Global License Agreement for Immunoprint Test Development in Melanoma Care

Akoya Biosciences and NeraCare announced a global license agreement to develop the Immunoprint test for early-stage melanoma.Quiver AI SummaryAkoya Biosciences, Inc. and NeraCare have entered into an exclusive...

AKYA : 2.49 (-2.35%)
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

AKYA : 2.49 (-2.35%)
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

AKYA : 2.49 (-2.35%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

/CNW/ -- USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is a global surge in cancer cases among people under...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
RCUS : 15.50 (+0.26%)
BCTX : 0.5610 (-4.12%)
ONC.TO : 1.19 (-9.16%)
AKYA : 2.49 (-2.35%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
RCUS : 15.50 (+0.26%)
BCTX : 0.5610 (-4.12%)
AKYA : 2.49 (-2.35%)
ONC.TO : 1.19 (-9.16%)
Akoya: Q3 Earnings Snapshot

Akoya: Q3 Earnings Snapshot

AKYA : 2.49 (-2.35%)
Akoya Biosciences Reports Third Quarter 2024 Financial Results

AKYA : 2.49 (-2.35%)
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel

AKYA : 2.49 (-2.35%)
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

AKYA : 2.49 (-2.35%)
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

AKYA : 2.49 (-2.35%)

Business Summary

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM)...

See More

Key Turning Points

3rd Resistance Point 2.87
2nd Resistance Point 2.74
1st Resistance Point 2.61
Last Price 2.49
1st Support Level 2.35
2nd Support Level 2.22
3rd Support Level 2.09

See More

52-Week High 6.31
Fibonacci 61.8% 4.62
Fibonacci 50% 4.09
Fibonacci 38.2% 3.57
Last Price 2.49
52-Week Low 1.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar